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Antibodies to solubilized cytochrome c oxidse and to subunit III were incubated with liposomal oxidase. 
In oxygen uptake experiments, the inhibiting effects on RCI of anti-oxidase (primarily anti- subunits II 
and IV) and anti-III were by different mechanisms: the former, by inhibiting the uncoupled rate; the latter, 
by stimulating the coupled rate. In experiments with H+ translocation, anti-oxidase was without effect, 
while anti-III was a potent inhibitor of proton pumping. These results are conclusive evidence for redox- 
linked proton extrusion from the vesicles by the oxidase (and its subunit III). 
Cytochrome c oxidase Reconstituted vesicle Proton pumping 
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1. INTRODUCTION 
There are two possible mechanisms of energy 
transduction by cytochrome c oxidase vesicles 
(COV). The first is that the electrochemical gra- 
dient is created as oxygen is reduced and cyto- 
chrome c oxidized on opposite sides of the mem- 
brane. The second mechanism is that the oxidase 
per se acts as a proton pump. There is no dispute 
about the former [1,2]; but as reviewed [3], there 
is much controversy as to whether the observations 
of a transient acidification of the medium-sus- 
pended COV, when these are pulsed with oxidants 
or reductants [5-lo], are evidence for the latter. If 
so, the inhibition of this proton translocation by 
DCCD [ 111, which binds to a glutamyl residue of 
subunit III [9], and the loss of proton pumping by 
COV prepared from enzyme lacking in the subunit 
1121 would not only constitute additional evidence, 
but actually localize the pumping to one part of the 
oxidase. 
Abbreviations: COV, cytochrome oxidase vesicles; 
DCCD, N,N’-dicyclohexylcarbodiimide; MOPS, mor- 
pholinopropane sulfonic acid; RCZ, respiratory control 
index 
Antibody 
However, alternative explanations have been 
proposed [13]: 
(i) Transient acidification could result artifac- 
tually from oxidation of a cytochrome c-phos- 
pholipid complex; 
(ii) DCCD might inhibit by interacting with the 
phospholipids of the complex, particularly 
phosphatidyl serine; 
(iii) The absence of acidification on pulsing COV 
prepared from the III-less enzyme might stem 
from residual detergent or changes in the 
quaterary structure of the remaining enzyme 
and their effect on the nature of the nearby 
cytochrome c-phospholipid complexes. 
Two of these explanations have been partially 
refuted [ 141: 
(i) Azide inhibition of acidification is not revers- 
ed by ferricyanide oxidation of cytochrome c 
(however, the soluble reagent may have ox- 
idized the cytochrome before it entered into a 
complex; 
(ii) DCCD inhibition did not correlate with the 
phosphatidyl serine content of the COV 
(however, other phospholipids might be 
susceptible elements of a complex). A clear 
resolution paper is needed. 
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In this laboratory, potent anti-oxidase and anti- 
subunit III rabbit sera are available. The former 
(predominantly anti- subuntis II and IV, but not 
III, as determined by Western blotting [15]) shows 
high titer in inhibiting (competitively with reduced 
cytochrome c) electron transport by the solubilized 
enzyme, and the latter affects electron transport 
only slightly and shows precipitin activity against 
subunit III alone [ 161. Thus there is a way to 
delicately, specifically, and unambiguously probe 
energy transduction by oxidase in general and sub- 
unit III in particular. 
2. MATERIALS AND METHODS 
2.1. Vesicular oxidase 
Published methods were used to prepare oxidase 
[ 15,17,18], and to incorporate it into vesicles [6] of 
partially purified [ 191 soybean phospholipids. 
Respiratory control indices varied from 3.75 to 
6.75. Oxygen uptake assays used conditions similar 
to [20]; uncoupling for respiratory control 
measurements was as in [7]. Proton translocation 
was at 3°C using phenol red [6] as modified by [7] 
except that the reduced cytochrome c was 
chromatographed and stored in 50 mM 
K$SOJl mM MOPS (pH 7.2). Protein determina- 
tion was as in [21], compensating for phospholipid 
interference. 
2.2. Immunological procedures 
Anti-III and anti-oxidase were raised and gam- 
ma globulin isolated as in [16], except that the 
gamma globulin preparations were used as stock 
solutions of 40-50 mg/ml in 50 mM KzS04 
(pH 7.5) and the data were recalculated to 20 mg 
gammagiobulin/ml. Incubation of these anti- 
bodies or non-immune gammaglobulin with the 
COV prior to oxygen uptake assay was for 15-20 
min at 4°C in 50 mM K2S04/l mM 
MOPS/pH 7.2 to a total volume of 2OO/rl of 
which 20 ~1 were COV. Oxygen uptake was in- 
itiated with 180 pl mixture. For each day’s assays, 
rates, percent inhibition or activation, and RCZ- 
values were corrected for the first-order decay of 
oxidase activity in the coupled and uncoupled 
states. 
Prior to proton translocation (in a 2.5 ml assay 
volume), the antibodies were incubated 15-20 min. 
in a total bolume of 2.0 ml 50 mM &S04, of 
which 200 ~1 were COV. The pH was brought to 
7.2 (using an electrode) immediately after the addi- 
tion of the COV, and again at the end of the in- 
cubation after the entire mixture was added to 
phenol red, valinomycin and K2SO4 in the concen- 
trations of [6] by adjusting the absorbance dif- 
ference to that of a pH 7.2 standard with additions 
of 10 mM KOH. The initial rates of proton extru- 
sion were measured, extending the straightline por- 
tion of the curve by correcting for the subsequent 
proton backflow into the vesicles. Any step ar- 
tifacts were graphically corrected. The buffering 
effect of the added protein was compensated by 
comparison with pulses of 5 nequiv. HCl at the end 
of each assay; however, such buffering imposed 
practical limits on the range of antibody/antigen 
ratio. 
3. RESULTS AND DISCUSSION 
3.1. Effect of antibodies on oxygen uptake 
The anti-oxidase was shown to inhibit 50% of 
spectrophotometrically measured activity of 
solubilized cytochrome c oxidase at a gamma 
globulin to oxidase ratio of < 1.5 pl/,ug [23]. The 
titer for the inhibition of oxygen uptake catalyzed 
by the solubilized enzyme was similar (about 1 
pl/pg), and increased to about 3.5 pl/pg in un- 
coupled vesicles (see fig.1). This loss of effec- 
tiveness is to be expected from the sequestration of 
part of the oxidase in the vesicles. Unexpected was 
the additional loss of effectiveness with respect to 
the coupled COV, for the same determinants are 
exposed. The simplest explanation is that bound 
anti-oxidase, in competitive equilibrium with 
substrate [23], could inhibit electron transport to 
oxygen only to the extent that a ‘leak’ relieved the 
transmembrane potential. If the observed 
respiratory control ratio represents an average of 
COV populations coupled to various degrees, the 
antibodies would be least effective against the best 
coupled particles, which contribute the most to 
proton translocation. This bode ill for the planned 
proton translocation studies. 
Anti-III had shown poor ability to inhibit elec- 
tron transport, requiring 17 ,&pg to produce half 
its maximum of 22% inhibition [23]. In fig.1 it is 
shown to be virtually ineffective against uncoupled 
COV in a practical range of ratios. However, it 
strongly stimulates the coupled particles with 
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Fig. 1. Quantitation of the effect of antibodies on oxygen 
uptake catalyzed by COV. Upward direction indicates 
inhibition: open symbols, effect in the presence of 1 pM 
valinomycin and 4,uM carbonyl cyanide m-chloro- 
phenylhydrazone (uncoupled); closed symbols, effect on 
coupled rates; circles, anti-oxidase; squares, non- 
immune globulin, triangles, anti-III. 
hyperbolic kinetics, approaching a maximum of 
90%; i.e., at infinite ratio, half the coupling would 
remain. Since, in this preparation, half the coupl- 
ing would still leave RCZ> 3, our results are consis- 
tent with the observation of RCZ in vesicles 
prepared form oxidase free of subunit III [22]. 
Inspection of fig.1 shows that both antibody 
- 
Fig.2. Proton translocation in the presence and absence 
of anti-III. For conditions, see section 2. At the arrow, 
0.24 mg oxidase in vesicles were pulsed with 20 ~1 
1.25 mM reduced cytochrome c. The COV had been in- 
cubated with: (A) no gamma globulin; (B) 0.58 pl anti- 
III/,ug oxidase; (C) 1.44 pl/pg; (D) 2.5 ,ul//cg. The 
horizontal bar is 10 s; vertical bars (downward), the ef- 
fect of 5 nequiv. of HCl on the assay mix. 
Table 1 
The effect of gammaglobulin on respiratory control 
index 
Preparation 
of gamma- 
globulin 
Ratio of 
gamma- 
globulin 
to antigen 
@l//lg) 
RCP % of 
controlb 
None 0 6.75 100 
Non-immune 7.5 6.97 104 
Anti-oxidase 4.0 4.40 59 
Anti-III 2.0 5.56 79 
4.0 5.14 72 
8.1 4.90 68 
Infinite 3.55 44 
a Calculated from rates compensated for first order 
decay of oxidase activity in coupled and uncoupled 
vesicles 
b 100 x (Experimental RCI - 1); 
Control RCI - 1 
Control was without 
globulin 
y 
I t cyto c 
1 
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Fig.3. Quantitation of antibodies on proton transloca- 
tion. The points are based on initial slopes, calculated as 
in section 2 from traces such as those of fig.2. For sym- 
bols see fig.1. 
preparations reduce the RCI. Anti-oxidase is max- 
imally effective in the central region, and anti-III 
as the antibody/antigen ratio is increased (see table 
1). Yet, clearly the mechanisms for these reduc- 
tions are different. In the absence of demonstrable 
anti-III content [15], that by anti-oxidase appears 
to be the result of a loss of its ability to inhibit an 
activity which has been reduced by coupling. 
However the effect of anti-III is to interfere with 
coupling to inhibit energy transduction but only 
half the energy is transduced. It seems to block one 
of two transduction mechanisms. This result im- 
mediately calls to mind work on vesicular III-less 
oxidase [23] in which RCI was halved by the 
removal of subunit III. Here a similar decrease in 
RCI was observed, but from the same COV 
preparation after exposure to anti-III (and not to 
non-immune gamma globulin, see fig.1) Since the 
III-less material had previously been shown unable 
to translocate protons [12], we were much en- 
couraged to try the effect of anti-III on proton 
translocation. 
The result is shown in fig.2. Even compensating 
for the increased buffering capacity due to the add- 
ed gamma globulin, it is clear that increasing ratios 
of anti-III/oxidase leads to increased inhibition. 
Fig.3 quantitates this relationship, showing also 
the effect of anti-oxidase and non-immune glob- 
ulin. As anticipated, the former is without effect, 
supporting our interpretation of fig. 1. Fortunate- 
ly, the non-specific effects, resulting from difficul- 
ty in measuring slopes in the face of buffering sup- 
plied by the globulin, do not show until outside the 
range wherein more than 3/4 of proton transloca- 
tion would be abolished by specific anti-III activi- 
ty. Recall this is a range where electron transport 
is unimpeded; electrons can still be removed from 
a cytochrome c-phospholipid complex. We have 
shown that, for this preparation (which showed an 
RCI> 6) the contribution of the artifact in [13] is 
not present. Non-specific interference with a cyto- 
chrome c-phospholipid complex by anti-III would 
be anticipated from non-immune globulin; yet it 
does not appear in this range. Nor can this effect 
be explained by residual detergent or drastic treat- 
ment to remove one subunit, thus disrupting the 
quaternary structure of the others. We are left only 
with an intimate involvement, possibly through the 
subtle conformational dynamics demonstrated in 
[ 151, of subunit III in proton pumping by cyto- 
chrome c oxidase. Moreover, the specificity of the 
subunit antibodies has enabled us to split energy 
translocation into its component mechanisms. It is 
our hope in the future to use the higher specificity 
of the monoclonal antibodies we are raising in this 
laboratory to probe structure-function relation- 
ships in the enzyme in still greater detail. 
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